TITLE

DTC Ads: A Link to Patient Safety?

AUTHOR(S)
Smith, Dorothy L.
PUB. DATE
June 2000
SOURCE
Pharmaceutical Executive;Jun2000, Vol. 20 Issue 6, p161
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on the ways to improve patient safety. How to prevent home medication errors; Information needed by consumers regarding the side effects of medications; Perspectives on medication risk management.
ACCESSION #
3280767

 

Related Articles

  • Does critical incident reporting contribute to medication error prevention? Frey, Bernhard; Buettiker, Vera; Hug, Maja I.; Waldvogel, Katharina; Gessler, Peter; Ghelfi, Daniela; Hodler, Catherine; Baenziger, Oskar // European Journal of Pediatrics;2002, Vol. 161 Issue 11, p594 

    Medication-related critical incidents (CIs) comprise harmful and potentially harmful events. The aim of CI monitoring is quality improvement through system changes. In a prospective survey, we analysed our drug-related CIs of the year 2001 with an emphasis on how they contributed to system...

  • Medication Safety.  // Journal of Pharmacy Practice & Research;Jun2015, Vol. 45 Issue 2, p211 

    The article covers issues related to medication issues and strategies for the prevention of medication errors as of June 2015. It discusses an incident in which a patient who needed midazolam was administered atracurium instead, a safety alert on the errors resulting from ambiguous course dosing...

  • Using drugs safely. Maxwell, Simon; Walley, Tom; Ferner, Robin E. // BMJ: British Medical Journal (International Edition);4/20/2002, Vol. 324 Issue 7343, p930 

    Editorial. Comments on the Audit Commission report, 'A Spoonful of Sugar,' which indicates a fivefold increase in ten years of medication errors or adverse reactions to medicines in Great Britain. Discussion of the Audit Commission's failure to distinguish between medication errors, inevitable...

  • Evaluation of a computer-based adverse-drug-event monitor. Soo-Hee Hwang; Sukhyan Lee; Hyun-Kyung Koo; Yoon Kim // American Journal of Health-System Pharmacy;12/1/2008, Vol. 65 Issue 23, p2265 

    Purpose. The performance of a computerbased adverse-drug-event (ADE) monitor is evaluated, and the characteristics of ADEs detected and undetected by the monitor are compared. Methods. A retrospective analysis was conducted to identify ADEs using predefined ADE alerts that were recognized by a...

  • Effectiveness of a pharmacist--nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care. Setter, Stephen M.; Corbett, Cynthia F.; Neumiller, Joshua J.; Gates, Brian J.; Sclar, David A.; Sonnett, Travis E. // American Journal of Health-System Pharmacy;11/15/2009, Vol. 66 Issue 22, p2027 

    Purpose. The effectiveness of a collaborative pharmacist-nurse intervention on resolving detected medication discrepancies as patients transitioned from hospital to home health care was evaluated. Methods. Patients age 50 years or older who were transitioning from hospital to home health care...

  • Preventable and Non-Preventable Adverse Drug Events in Hospitalized Patients. Dequito, Aileen B.; Mo, Peter G. M.; van Doormaal, Jasperien E.; Zaal, Rianne J.; van den Bemt, Patricia M. L. A.; Haaijer-Ruskamp, Flora M.; Kosterink, Jos G. W. // Drug Safety;2011, Vol. 34 Issue 11, p1089 

    Background: Medication safety research and clinical pharmacy practice today is primarily focused on managing preventable adverse drug events (pADEs). Determinants of both pADEs and non-preventable adverse drug reactions (ADRs) have been identified. However, relatively little is known on the...

  • Big transitions in care -- next wave in the health reform revolution. FREDERICK, JIM // Drug Store News;11/16/2015, Vol. 37 Issue 11, p16 

    The article focuses on the trend for big transitions in care as part of the health reform revolution in the U.S. It discusses hospital readmissions caused by medication errors, nonadherence and adverse drug events, the role of medication management in controlling hospital costs and the...

  • Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions. Geerts, Arjen F. J.; De Koning, Fred H. P.; De Smet, Peter A. G. M.; Van Solinge, Wouter W.; Egberts, Tome C. G. // Drug Safety;2009, Vol. 32 Issue 12, p1189 

    Background:. Patient safety and the life cycle of a drug are negatively influenced by the still increasing occurrence of potential drug-drug interactions (DDIs). Clinical risk management of potential DDIs is required in patients using drugs to influence the benefit-risk profile positively....

  • Triggers point way to ADEs. Ukens, Carol // Drug Topics;6/21/2004, Vol. 148 Issue 12, pHSE1 

    This article talks about the benefits of a low technology, relatively low cost adverse drug event (ADE) trigger tool which keeps track of medication errors. The ADE trigger tool is a list of sentinel words, such as drug name, that point to a possible ADE or medication error. It takes about an...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics